Click here for an Adobe PDF version of this document. (180KB PDF, Viewing Information) NEW: Please take a moment to evaluate our birth defects risk factor series. Click here to take survey.

Anal atresia/stenosis is the absence, closure, or constriction of the rectum or anus. It includes the diagnosis of imperforate anus. This condition is one of the more common defects of the gastrointestinal tract (Forrester 2002). Anal atresia/stenosis is usually diagnosed shortly after delivery. While anal atresia/stenosis can occur as an isolated defect, it is often associated with other birth defects (Forrester 2002, Garne 2002, Haeusler 2002, Stoll 1996, Harris 1995, Castilla1990). Anal atresia/stenosis is often associated with a group of defects called the VACTERL syndrome; this syndrome causes vertebral, anal, cardiac, trachea, esophageal, renal, and limb abnormalities (Moore 1998). This defect can also be associated with chromosomal abnormalities, particularly trisomy 21 (Haeusler 2002, Bianco 2000, Torfs 1998, Stoll 1997, Kallen 1996, Harris 1995).

While some studies failed to find a significant association between race/ethnicity and anal atresia/stenosis (Stoll 1997, Yang 1994), several studies have reported the anal atresia/stenosis rate to be slightly lower in African-Americans (Harris 1995, Chavez 1988), and another reported the rate of rectal/anal atresia to be higher in Europeans and South Asians than in Caribbeans (Leck 1995). A New York study found atresia/stenosis of the anus or rectum to be significantly lower among Mexican-born Hispanic women when compared with Hispanic mothers born in the U.S., Cuba, or Central/South America (Zhu 2006). More than one investigation found no secular trend for anal atresia/stenosis (Forrester 2002, Spouge 1986), while another investigation reported an increase in the rate of the defects over time (Yang 1994). Anal atresia/stenosis does not appear to demonstrate seasonal variation (Stoll 1997, Castilla 1990). Geographic location does not affect risk for anal atresia/stenosis (Stoll et al., 1997), except that one investigation identified an increased risk of the defects with higher altitude (Castilla 1999). The association between anal atresia/stenosis and maternal age has been reported to be U-shaped (Harris 1995, Yang 1994) or to increase with increasing maternal age (Myers 2001), although another study found no association between maternal age and the condition (Stoll 1997). However, one confounding factor is that advanced maternal age is associated with an increase in chromosomal abnormalities (which often produce multiple defects); there is limited data available for non chromosomal or isolated anal atresia/stenosis (Forrester 2002, Cuschieri 2001). Paternal age does not appear to influence anal atresia/stenosis risk (Stoll 1997, McIntosh 1995). Infant sex may influence anal atresia/stenosis risk, with the condition being more common among males (Lisi 2005, Haeusler 2002, Lary 2001, Myers 2001, Cuschieri 2001, Riley 1998, Harris 1995, Spouge 1986), although several studies found no relationship between sex and anal atresia/stenosis (Stoll 1997, Yang 1994). Anal atresia/stenosis risk increases with lower birth weight (Riley 1998, Stoll 1997, Mili 1991) but is not associated with large for gestational age (Lapunzina 2002). Anal atresia/stenosis risk is elevated with prematurity (Rasmussen 2001). Large intestinal atresia has been associated with intrauterine

Shiono 1986). ampicillin. Van Den Eeden 1990. Early Hum Dev 2001. a different investigation reported no such associations (Stoll 1997). a combination of trimethoprim and sulfamethoxazole that is a folic acid antagonist. flu. Khoury 1989). Doyle 1991. A review article noted increased risk of anal atresia/stenosis with paternal occupation of vehicle manufacturer (Chia 2002). fever. Spouge 1986). however.23 cases per 10. Czeizel 2001b. Various i sti ations found a decrease in risk of these defects with increasing parity and an increase in risk with multiple gestation pregnancy (Mastroiacovo 1999. Kallen 1986). medazepam. and clonazepam and recto-anal atresia or stenosis (Eros 2002. FACT IN LIFE TYLE OR ENVIRONMENT Maternal education does not appear to affect risk for anal atresia/stenosis (Stoll 1997). whil e bromazepam was associated with other digestive system anomalies (Bonnot 2001). One investigation identified no significant association between maternal nursing occupation and risk of atresia/stenosis of the colon. Becerra 1990). or anus (Matte 1993).61:85-95. Paternal occupations of printing or sales do not appear to increase risk of rectal atresia (Irgens 2000). failed to find any association between the medication and anal-rectal atresia/stenosis (Czeizel 1990). An investigation failed to identify any significant association between anal atresia and proximity to various types of industry (Castilla 2000). although one investigation observed increased risk of atresia of rectum. One study observed no association between maternal use of the antibiotic oxytetracycline during pregnancy and rectal-anal atresia/stenosis (Czeizel 2000 and others found no relationship between cephalosporin antibiotics. However. Maternal smoking and exposure to X-rays do not appear to cause anal atresia/stenosis (Honein 2001. PREVALENCE Birth prevalence in the United States for anal atresia/stenosis ranges between 1. Kallen B. or the benzodiazepines nitrazepam. A small percentage of cases with anal atresia/stenosis have a family history of the same defect (Stoll 1997. anal canal. REFERENCE y Aberg A. Yuan 1995. Stoll 1997. or maternal exposure to indoor pesticides (Berkowitz 2003). 2000).04 and 7. While there is limited data on the effects of illicit drugs on fetal develo pment. hypertension. rectum. while another more recent investigation identified reduced risk of imperforate anus with maternal use of folic acid (Myers 2001). Investigations into the association between alcohol and anal atresia/stenosis are mixed (Bianchi 2000. nalidixic acid. Maternal diabetes may increase risk for anal atresia/stenosis (Aberg 2001. Westbom L. hypothyroidism. The use of cocaine also has not been shown to increase the risk of anal atresia/stenosis (Chavez 1989). There is also an apparent association between anti asthmatic drugs and anal atresia (Kallen 2007). Bianchi 2000. first trimester maternal exposure to lorazepam does increase the risk for anal atresia. Living in proximity to hazardous waste sites has not been found to affect risk of anal atresia (Dolk 1998). Riley 1998. Anal atresia does not appear to be related to water chlorination (Kallen and Robert. Stoll 1997).000 live births (includes atresia or stenosis of the large intestine) (Texas Department of State Health Services 2006). Harris 1995. No association between maternal folic acid use and anal atresia was found by one study (Czeizel 1996). the use of marijuana does not increase the risk of anal atresia/stenosis (Fried 2002). Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. The rate in Texas among 1999-2003 deliveries was 5. There is no apparent association between anal atresia/stenosis and maternal epilepsy. maternal exposure to organic solvents (Wennborg 2005). tofisopam. Czeizel 2001a. Anal atresia/stenosis has been reported in infants whose mothers took thalidomide during pregnancy (Bianchi 2000). alprazolum. Stoll 1997.growth retardation (Khoury 1988). Furthermore. One study identified higher risk of anal atresia/stenosis with consanguinity (Stoll 1997) while another study found no association (Rittler 2001). ¤ £ ¢¡  . or hyperthyroidism (Stoll 1997. Differences in prevalence may be due to differences in case inclusion criteria. Czeizel 2001c). One study reported no increased risk of skin-covered anus in regions of Belarus contaminated after the Chernobyl accident (Feshchenko 2002).000 live births ( National Center on Birth Defects and Developmental Disabilities 2006). Anorectal malformations have been associated when assisted reproductive techniques were used in conception of the fetus (Midrio 2006). although one investigation reported no association between imperforate anus and diabetes (Ramos-Arroyo 1992).89 per 10. and large intestine with maternal smoking (Cornel 1996). a study that examined co-trimoxazole. There appears to be higher rates of all non-chromosomal anomalies within groups with low socioeconomic status (Vrijheid 2000).

Am J Obstet Gynecol 2001c. urban cohort. Vollset S. 2003.59:149-155. Economic activity and congenital anomalies: an ecologic study in Argentina. Altitude as a risk factor for congenital anomalies. Eur J Epidemiol 1987. Olsen J. No. . 1. Khoury MJ. Cordero JF. Toth M.8:197-209. Springer-Verlag. Environ Health Perspect 2000. Olsen J. Review of recent epidemiological studies on paternal occupations and birth defects. Mulinare J. Vrijheid M.108:193-197. Risk of congenital anomalies near hazardous-waste landfill sites in Europe: the EUROHAZCON study. Leading major congenital malformations among minority groups in the United States. Stone D. Berkowitz. Cordero JF: Maternal cocaine use during early pregnancy as a risk factor for congenital urogenital anomalies. pp. 499-505. Bianco S. Use of cephalosporins during pregnancy and in the presence of congenital abnormalities: a population-based. Khoury MJ. In: Fetology: Diagnosis and Management of the Fetal Patient. No. Castilla EE. Exposeure to indoor pesticides during pregnancy in a multiethnic. J. Sorensen HT. Godet P. Robert E. James LM. Liu Y. Z. Obel. P. Population-based birth-defect and risk factor surveillance: data from the Northern Netherlands. Sorensen HT.37:17-24. Spagnolo A. Nelen V. Lopez-Camelo JS. Am J Med Genet 2001. R. Erickson JD. Eur J Obstet Gynecol Reprod Biol 2000. Cavazzuti GB. Abramsky L. Godbold. Dutra GP. Lopez -Camelo JS. northern Italy: comparison with the EUROCAT data. 21. Cocchi G. Volpato S. Roncarati E. Environmental Health Perspectives. Liu. Am J Obstet Gynecol 2001a. Sorensen HT. Erickson JD. Garne E. Lapinski. Lopez-Camelo JS. 111. Acta Paediatr Acad Sci Hung 1981.22:299-308. Chavez GG. A case-control analysis of the teratogenic effects of co-trimoxazole. New York: McGraw-Hill. Vitez M. Castilla EE. Lancet 1998. G. Maternal exposure to lorazepam and anal atresia in newborns: results from a hypothesis-generating study of benzodiazepines and malformations. Landrigan. 1990 pp. Int J Gynaecol Obstet 2001b. Paediatr Perinat Epidemiol 2000. Rockenbauer M. Cornel MC.53:345-351. Castilla EE. 4. Czeizel A. Bianchi DW. Pediatrics 1990. Cuschieri A. Dolk H. Moretti M. Campana HE. 2002. Congenital malformations in 100. Reprod Toxicol 1990. Wolff. Deych. Mor Mortal Wkly Rep CDC Surveill Summ 1988.3:423-430. Castilla EE.14:372. Journal of Clinical Psychopharmacol. Calzolari E. Czeizel AE. Czeizel AE. Descriptive epidemiology of isolated anal anomalies: a survey of 4.185:140-147. Cordero JF. D¶Amato T. Olsen J. Anorectal malformations and Down¶s syndrome. Magnani C. Salvioli GP. Lugarinho R.103:207-215. 262:795-8.86:9-14. Scott JE. 2000.y y y y y y y y y y y y y y y y y y y y y y Becerra JE. New York.352:423-427. Mastroiacovo P. Czeizel AE. Vol. Campana H. Becerra JE. Tenconi R.85:1-9.19:399-404. JAMA 1989. A population-based case-control teratologic study of nalidixic acid. Rockenbauer M. A population-based case-control teratologic study of ampicillin treatment during pregnancy. Czeizel A. Shi LM. Monthly and seasonal variations in the frequency of congenital anomalies. Birth prevalence of five congenital abnormalities of medium frequency in Budapest. Crombleholme TM. Int J Risk Safety Med 1996. Int J Epidemiol 1990. The surveillance of birth defects in South America: I. J. Rockenbauer M. Vol. Ettore G. Am J Med Genet 1999. Camelo JS. Anorectal atresia (imperforate anus). Armstrong B. 191-210. In: Advances in Mutagenesis Research. Population-based case control study of folic acid supplementation during pregnancy. Orioli IM. Campana H. Occup Environ Med. Czeizel AE. Contrino C. Bonnot O. Teratology 1996.6 million births in Europe. Czeizel AE. Bianchi F. Rockenbauer M. 2001.4:305-313. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. The search for time clusters: epidemics.184:1289-1296. EUROCAT Working Group. Robert E. Chavez GF. 1981-1986.73:221-228. Chia SE. D¶Alton ME.000 consecutive births in Emilia Romagna region. A population-based case-control teratologic study of oral oxytetracycline treatment during pregnancy. case-control study. Rockenbauer M.88:2733.

sciences. Lapunzina P. Bianca S. Gustavson KH. Muller WE. Becerra JE. d'Almada PJ. Sorensen HT. Robert E. Reprod Toxicol 2000.82:83-90.12:101-106. in Birmingham. Fried P. Hall TM. 3. Hurst DC. and Merz R. alprazolum and clonazepam treatment during pregnancy. American Journal of Medical Genetics. Rittler M. Hypotheses tested in a record linkage based dataset. Erratum in: Am J Med Geet A.134(4):463. No.64:237-251. ¾. medazepam. Khoury MJ. Olsen J. Kallen B. Denmark epidemiology. Paulozzi LJ. and Uppsala County.79:465470. Berghold A. Vol. Pharmacol. Irgens A. Botting B.65:160-166. Lary JM. Lazjuk GI. Erickson JD. 2005 Apr 1. De Walle H. 2007 Apr. England. associated malformations. Mastroiacovo P. Husby S. 2.101:147-154. J Epidemiol Community Health 1995. Botto LD. Ritvanen A. Watkins ML. Maternal thyroid disease and risk of birth defects in offspring: a population-based case-control study. 2005 May 1. Acta Obstet Gynecol Scand 2000. Public Health Rep 2001. Irgens L. Barganier CM. Mastroiacovo P. J Pediatr 2002. Leck I. South Med J 1994. Skorve AH. Wiedmeyer JA.49:171-179. Cell Mol Biol 2002. Teratology 66: S12-S16. Scarano G. Castilla E. Gatt M. 1986 -1999. Goujard J. genital. Marinacci C. Major congenital malformations in Down syndrom e. Congenital malformations among newborns and developmental abnormalities among human embryos in Belarus after Chernobyl accident.45:43-48. Merlob P. Finley WH. Eur. Forrester M. Prenatal ultrasonographic detection of gastrointestinal obstruction: results from 18 European congenital anomaly registries. Castilla EE. Kallen B. Irgens LM. Sex differences in the prevalence of human birth defects: a population based study. Ritvanen A. Congenital malformations in twins: an international study. Harris J. McCarthy BJ. Eros E. Sex and congenital malformations: an international perspective. Robert E. Schroder HC. Barisic I. Eur J Obstet Gynecol Reprod Biol 2002. Metneki J.3:402-420. Birth defects surveillance: Jefferson County.22:616-623. Rittler M.140:200-204.83:117-124. Mutchinick OM. 2002. Rasmussen L. 2000. Lisi A.48:423-426. Merlob P. Kallen BA.134(1):49-57. Rodriguez-Pinella E. Lancashire RJ. Am J Med Genet A. Risks of congenital a nomalies in large for gestational age infants. Rockenbauer M. 2002. Mutchinick O. Am J Med Genet 1999. tofisopam. Mastroiacovo P. Castilla EE. Women and Cannabis: medicine. Teratology 1995. Kallen B. Teratology 2001.63(4):383 -8. A population -based case-control teratologic study of nitrazepam. Olausson PO. Maternal smoking and birth defects: validity of birth certificate data for effect estimation. Eric kson JD. Congenital malformati ons in twins in England and Wales. Botting B. Anal atresia. De Vigan C. J Epidemiol Community Health 1991.52:15-29. Prenat Diagn 2002. Bianchi F. Clementi M. Birth prevalence of malformations in members of different ethnic groups and in the offspring of matings between them.87:440-445. Arpino C.116:327-335. Stoll C.14:303-309. Kruger K. Botting B. Use of anti-asthmatic drugs during pregnancy. Wale CJ. Lancaster P. Am J Med Genet 1996. Johnson W. Descriptive epidemiology of anal atresia in Hawaii. Haeusler MC. Drinking water chlori nation and delivery outcome-a registry-based study in Sweden. Paulozzi LJ. Stoll C. Alabama. Beral V. and sociology (2002) and Journal of Cannabis Theraputics.y y y y y y y y y y y y y y y y y y y y y y Doyle PE. Congenital malformations in the infants. Lopez Camelo JS. 95: 169-173. Sweden. vertebral. J. The consequesnces of marijuana use during pregnancy: a review of the literature. Rosano A. surgery and mortality. Honein MA. Garne E. Robert E. Robert E. Cordero JF. Birth defects and paternal occupational exposure. Pediatrics 1988. Czeizel AE. Congenital malformations and intrauterine growth retardation: a population study. Martinez-Frias M. Clin. Cocchi G. Feshchenko SP. Paediatr Perinat Epidemiol 1989. Eur J Pediatr Surg 2002. Permejo E. Descriptive epidemiology of alimentary tract atresia. and urinary tract anomalies: a primary polytopic developmental field defect identified through an epidemiological analysis of associations. Epub 2007 Feb 6. Gastrointestinal malformations in Funen C ounty. Khoury MJ. .

Eur J Epidemiol 1 996.000 consecutive liveborn infants. y Stoll C. Congenital malformations in Victoria. A case -control study of maternal smoking and congenital malformations. Case -control study of congenital defects and parental employment in health care. Edmonds LD. Birth defects surveillance data from selected states. Arch Dis Child. Karagas MR. 1983 95: an overview of infant characteristics. Maternal diabetes: the risk for specific birth defects. Anomalies in Down syndrome individuals in a large population based registry. 2006.154:10511056.145:1313-1318. Please Note: The primary purpose of this report is to provide background necessary for conducting cluster investigations. y Sekhobo JP. Roth MP. Moore CA. Comparative epidemiology of selected midline congenital abnormalities. Erickson JD.24:11-23. Paulozzi LJ.102:36-43. Alembik Y.Matte TD. y Rasmussen SA. Risk for birth defects among premature infants: A population-based study. y Spouge D. Di Gianantonio E. Part A Clin. Roth MP. Texas Birth Defects registry report of birth defects among 1999-2003 deliveries. Magnusson L. Liascovich R. Epub 2006 May 16. Okazaki I. Congenital malformations related to maternal exposure to specific agents in biomedial research laboratories. y Stoll C. JOEM 2005:47(1). Baird PA. y Mili F. Beaty TH.8:503-508.6:282-288. 2006 Nov. Eur J Epidemiol 1992. K. Mol. Dott B. Public Health Rep 2001. Parental consanguinity in specific types of congenital anomalies. Daling JR. Mulinare J. Halliday JL. Christianson RE. The strengths and limitations of each reference were not critically examined prior to inclusion in this report. Rhodenhiser EP.38:32-43. y Riley MM. Australia. 82. Beatty JC.77:431-438. Mol. y Wennborg H. Lopez-Camelo J. y Zhu M. Distribution of single organ malformations in European populations. Consumers and professionals using this information are advised to consult the references given y . 2006 Dec. Congenital malformations and maternal smoking during pregnancy. Kuroki Y. Birth Defects Res. Moore CA. Olshan AF. Clementi M. Li S. Socioeconomic inequalities in the risk of congenial anomaly. Birth Defects Res. Druschel CM.12:611-616. McClearn AB. Am J Dis Child 1991. Maternal birthplace and major congenital malformations among New York Hispanics. Prevalence of birth defects among low birth-weight infants. Diamond EL. Ann Genet 1997. Castilla EE. y Shiono PH. Lin S.76(6):467 -73. Am J Med Genet Suppl 1986. Folic acid supplementation and risk for imperforate anus in China. Hong SX. Khoury MJ. J Paediatr Child Health 1998. y Torfs CP. Berendes HW. Cordero JF. y Moore. J Pediatr 2001. 2006 Jun. y Vrijheid M. EUROCAT Working Group. Alembik Y. Persaud.76(12):894-960. The developing human: clinically orientated embryology.11:141-154. y Van Den Eeden SK.34:233-240. It summarizes literature about risk factors associated with this defect. y Myers MF. y McIntosh GC.116:296-305. T. Berry RJ. Olsen J. Rodriguez-Pinilla E. Genet Epidemiol 1994. 1998. Anal atresia: effect of smoking and drinking habits during pregnancy. Jpn J Hum Genet 1995.34:65-71. An evaluation of congenital malformations surveillance in New York State: an application of Centers for Disease Control and Prevention (CDC) guidelines for evaluating surveillance systems. Alberman E. y Midrio P. A population study. y Texas Department of State Health Services. Imperforate anus in 700. Stewart WF. Am J Med Genet 2001. Abramsky L. Scott J.138:668-673. Am J Epidemiol 2001.40:197-204. Gordis L. Centers for Disease Control and Prevention. Vaughan TL. Toxicol. Stone D. y Ramos-Arroyo MA. Am J Ind Med 1993.22(4):576-7. Lumley JM. y Stoll C. y Yuan P.2:151-161. Paternal age and the risk of birth defects in offspring. Li Z. Epidemiology 1995. Baird PA. 349-352. Teratol. Am J Med Genet 1998. Nogare CD. Correa-Villasenor A. Part A Clin. Bonde J. Chee E. Ann Genet 1995. y National Center on Birth Defects and Developmental Disabilitie s. Dott B. Paediatr Perinat Epidemiol 1990. 1999-2003. y Yang P. y Rittler M. Druschel C.40:327-332. Are congenital anorectal malformations more frequent in newborns conceived with assisted reproductive techniques? Reprod. Klebanoff MA. 2000. Dolk H. Teratol. Teratology 1986.4:147-155. Evaluation of prenatal diagnosis of congenital gastro intestinal atresias. Risk factors in congenital anal atresias. Khoury MJ.

mitigate. treat.for more in-depth information. . Individuals affected by this condition should consult their physician and when appropriate. or prevent disease or other conditions and is not intended to provide a determination or assessment of the state of health. seek genetic counseling. This report is for information purposes only and is not intended to diagnose. cure.